LumiraDx
Delivers connected diagnostics and diagnostic-led care solutions.
Launch date
Employees
Market cap
AUD7.1m
Enterprise valuation
AUD590m (Public information from Jan 2024)
Share price
$0.016 LMDX
Company register number 09206123
London England (HQ)
Financials
Estimates*
| EUR | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenues | - | 21.0m | 127m | 383m | 231m | 82.7m | 124m |
| % growth | - | - | 501 % | 203 % | (40 %) | (64 %) | 50 % |
| EBITDA | - | (116m) | (108m) | 41.6m | (249m) | - | - |
| % EBITDA margin | - | (550 %) | (85 %) | 11 % | (107 %) | - | - |
| Profit | - | (121m) | (219m) | (92.0m) | (409m) | - | - |
| % profit margin | - | (574 %) | (173 %) | (24 %) | (177 %) | - | - |
| R&D budget | 56.0m | 78.7m | 97.8m | 118m | 129m | - | - |
| R&D % of revenue | - | 374 % | 77 % | 31 % | 56 % | - | - |
Source: Dealroom estimates
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | $610k | Seed | |
| N/A | $75.2m | Debt | |
| N/A | $164m | Late VC | |
$400m | Post IPO Debt | ||
$115m Valuation: $3.0b 21.6x EV/LTM Revenues -25.3x EV/LTM EBITDA | SPAC IPO | ||
$700m | SPAC Private Placement | ||
* | N/A | $56.5m | Post IPO Convertible |
* | $14.2m | Grant | |
| Total Funding | AUD1.4b | ||
